# Bioequivalence Study of Generic Celecoxib 200 mg Capsules

> **NCT06337422** · PHASE1 · UNKNOWN · sponsor: **International Bio service** · enrollment: 40 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Celecoxib 200 mg capsule

## Key facts

- **NCT ID:** NCT06337422
- **Lead sponsor:** International Bio service
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-09-23
- **Primary completion:** 2024-09-27
- **Final completion:** 2024-10-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06337422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06337422, "Bioequivalence Study of Generic Celecoxib 200 mg Capsules". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06337422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*